The debate over kratom regulation in Idaho persists following a recent federal move to restrict specific synthetic opioid compounds derived from the plant. As reported by idahostatejournal.com, the U.S. Department of Justice announced a temporary ban last week on three potent substances: mitragynine psedoindoxyl (MGPI), GMG-15, and MGM-15.
These compounds have been classified as Schedule I controlled substances. MGPI is a derivative of 7-hydroxymitragynine (7-OH), while GMG-15 and MGM-15 are semi-synthetic derivatives sold specifically for their opioid effects. The Drug Enforcement Administration cited preclinical evidence indicating these banned compounds act as mu-opioid receptor agonists, posing significant risks of dependence and respiratory depression.
Why It Matters
Natural kratom remains exempt from the federal ban provided it meets appropriate 7-OH thresholds. Natural kratom typically contains a 7-OH concentration below 2 percent, whereas synthetic alternatives can reach concentrations as high as 98 percent. A separate federal proposal to schedule 7-OH above 0.05 percent by dry weight is currently pending but has not yet been formalized under the Controlled Substances Act.
Idaho currently lacks statewide regulation for kratom after previous legislative efforts to ban or regulate the substance failed. This regulatory gap leaves local jurisdictions and health officials to manage public safety concerns independently. For context on other state-level policy adjustments, readers may note that Idaho Officials Aim to Hold Agency Budgets Flat for Fiscal Year 2028 as the state navigates various administrative challenges.
What Happened
Bonneville County Coroner Shante Sanchez issued a public health alert in October 2025 linking kratom to fatalities in the region. At the time of that bulletin, there were six kratom-related deaths recorded in Bonneville County. Four of those deaths were attributed solely to acute toxicity of mitragynine.
Sanchez reported nine additional deaths where kratom was a contributing factor or official cause via mixed-drug toxicity or acute intoxication. Three other deaths involved individuals with kratom in their system, though it was not listed as a contributing factor. Toxicology screenings for these cases rely on National Medical Services (NMS) Laboratories using a 162-point panel.
Sanchez testified before the Idaho Falls city council in favor of an outright ban on the substance. The Idaho Falls city council subsequently prohibited kratom sales via an ordinance effective July 1. This local action highlights the divergence between state-level inaction and municipal responses to public health data.
By The Numbers
- Three: Number of potent opioid compounds temporarily banned by the DOJ.
- Schedule I: Classification assigned to the three banned compounds.
- 0.05 percent: Threshold for pending federal scheduling of 7-OH in raw plant material.
- 2 percent: Maximum 7-OH concentration in natural kratom.
- 98 percent: Maximum 7-OH concentration in synthetic alternatives.
Zoom Out
Kratom has been present on the American market since the early 2000s. The earliest published report on kratom dependence problems appeared in 2010. Dr. Norman Litchfield, a psychiatrist and addiction medicine specialist with St. Luke’s, became aware of kratom issues approximately 10 years ago.
Litchfield serves as president of the Idaho Chapter of the American Society of Addiction Medicine. He noted that effects akin to antidepressants or ADHD medications occur at low doses. However, effects change when consuming above 40 milligrams of mitragynine. Above that threshold, kratom acts on mu-opioid receptors similar to opioid pain medications.
The American Society of Addiction Medicine broadly opposes total bans on substances of abuse. This stance reflects a broader medical community perspective that favors regulation and treatment over prohibition. The federal ban targets synthetic derivatives rather than the natural plant, aiming to curb dangerous products while preserving access for those who use kratom responsibly.
What’s Next
The pending federal proposal to schedule 7-OH above 0.05 percent by dry weight remains under review. If formalized, this could significantly impact the availability of natural kratom products that exceed this threshold. Idaho lawmakers may revisit regulation efforts in light of new federal actions and local public health data.
Local jurisdictions like Idaho Falls have already taken steps to restrict sales. Other cities and counties may follow suit if death tolls or health concerns rise. The state’s lack of comprehensive kratom policy leaves a patchwork of regulations that could evolve as more information becomes available.
For additional context on state operations, Idaho Expands Self-Service Vehicle Registration to Grocery Stores demonstrates ongoing efforts to improve government services. Meanwhile, Idaho Water Utilities Heighten Cybersecurity After Summer Attacks on U.S. Infrastructure underscores the importance of safeguarding critical systems against emerging threats.
About the Author
